Tagged as: pharmaceutical cancer
Takeda’s Actos Settlement Falls Short
A $2.37 billion dollar deal to settle thousands of lawsuits related to Takeda's cancer-causing diabetes drug Actos is in the works. But the settlement may not make it to the final stages if claimants continue to hold out for higher payouts.Takeda Pharm...